Finance

Lists
VAISHALI:NSE
Vaishali Pharma Ltd
7,86 ₹
+0,90%
(+0,070) 1D
16 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for VAISHALI...
Open
7,95 ₹
High
7,95 ₹
Low
7,60 ₹
Mkt. cap
1,06 млрд
Avg. vol.
158,85 м.
Volume
96,80 мың
P/E ratio
10,85
52-wk high
11,15 ₹
52-wk low
4,75 ₹
EPS
0,72 ₹
No. of employees
30
Open
7,95 ₹
High
7,95 ₹
Low
7,60 ₹
Mkt. cap
1,06 млрд
Avg. vol.
158,85 м.
Volume
96,80 мың
P/E ratio
10,85
52-wk high
11,15 ₹
52-wk low
4,75 ₹
EPS
0,72 ₹
No. of employees
30
News stories
From web sources and news partners
About Vaishali Pharma Ltd
CEO-
Employees30
Founded1989
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 14 там.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
228,91 млн / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
334,46 млн
246,52 млн
269,27 млн
228,91 млн
Cost of goods sold
296,97 млн
209,37 млн
245,34 млн
194,41 млн
Cost of revenue
296,97 млн
209,37 млн
245,34 млн
194,41 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,32 млн
7,22 млн
11,39 млн
7,18 млн
Operating expense
25,32 млн
22,82 млн
27,55 млн
21,02 млн
Total operating expenses
322,28 млн
232,19 млн
272,89 млн
215,43 млн
Operating income
12,18 млн
14,33 млн
-3,62 млн
13,49 млн
Other non operating income
8,39 млн
8,92 млн
-20,98 млн
5,80 млн
EBT including unusual items
16,58 млн
18,33 млн
2,94 млн
17,89 млн
EBT excluding unusual items
16,58 млн
18,33 млн
2,94 млн
17,89 млн
Income tax expense
4,72 млн
5,15 млн
-870,00 м.
2,42 млн
Effective tax rate
28,44%
28,09%
-29,57%
13,56%
Other operating expenses
17,28 млн
14,33 млн
-6,49 млн
12,48 млн
Net income
11,86 млн
13,18 млн
3,81 млн
15,46 млн
Net profit margin
3,55%
5,35%
1,42%
6,75%
Earnings per share
-
-
-
-
Interest and investment income
-
-
29,18 млн
-
Interest expense
-4,01 млн
-5,08 млн
-7,21 млн
-1,96 млн
Net interest expenses
-4,01 млн
-5,08 млн
21,97 млн
-1,96 млн
Depreciation and amortization charges
1,72 млн
1,27 млн
1,59 млн
1,37 млн
EBITDA
12,79 млн
14,94 млн
-2,77 млн
14,85 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары